This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Innate Pharma. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Caroline Denis: Innovator in Cancer Treatment
Introduction
Caroline Denis is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of cancer treatment through her innovative research and development.
Latest Patents
Caroline Denis holds one patent titled "Neutralization of inhibitory pathways in lymphocytes." This invention focuses on the use of NKG2A-neutralizing agents to treat cancers that are poorly responsive to PD-1 neutralizing agents. Additionally, it explores the combined use of NKG2A-neutralizing agents and PD-1 neutralizing agents for effective cancer treatment.
Career Highlights
Caroline Denis is associated with Innate Pharma, a company dedicated to advancing cancer therapies. Her work has been instrumental in developing new strategies for cancer treatment, showcasing her expertise and commitment to improving patient outcomes.
Collaborations
Throughout her career, Caroline has collaborated with notable colleagues, including Pascale Andre and Mathieu Blery. These partnerships have further enhanced her research and contributed to the advancement of cancer therapies.
Conclusion
Caroline Denis is a trailblazer in the field of cancer treatment, with her innovative patent and collaborative efforts paving the way for new therapeutic approaches. Her work continues to inspire advancements in medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile